William B Shepro

CEO Shepro buys 3,511 ASPS shares at $6.02; prior same-ticker buys posted 90d returns of +1338.5%, +172.5%, +177.3%

William B Shepro, Chair and CEO, purchased 3,511 shares of ALTISOURCE PORTFOLIO SOLUTIONS S.A. at $6.02 on 2026-05-22, increasing holdings to 236,750 shares. This transaction merits attention due to a strong pattern in his prior same-ticker history: his three prior open-market buys at ASPS posted 90-day returns of +1338.5%, +172.5%, and +177.3%, with 3 of 3 well-timed at the 90-day mark. The current price of $6.64 sits 58.4% below the 52-week high of $15.96 and reflects a -22.3% decline over the past 90 days, despite a +4.6% rebound in the last 30 days. Fundamentals show revenue of $47.6M in the latest quarter with a net loss of $531.0K and annual revenue growth of +6.8%, against a market cap of $74.9M. Investors should monitor whether this buy follows the prior pattern of capturing subsequent upside at this ticker.

ASPS Chairman/CEO Shepro buys 210,498 shares at $0.48; post-trade holdings 1,239,474 shares (+20.5%); stock -68.0% from 52-week high.

Shepro William B, Chairman and CEO, purchased 210,498 shares at $0.48 on 2025-03-28, increasing his holdings by 20.5% from 1,028,976 to 1,239,474 shares. The current price is $2.64, meaning the stock has appreciated materially since the transaction at $0.48. At the same ASPS ticker, Shepro's prior two measurable buy transactions (2024-03-18 and 2024-03-14) both showed 90-day returns of +172.5% and +177.3% respectively, indicating a consistent pattern of well-timed entry points at this specific stock. The company remains unprofitable (net income $-9.3M in the latest quarter) despite 10.4% annual revenue growth, and the stock stands -68.0% below its 52-week high, creating a tension between fundamental weakness and insider accumulation at a deeply depressed valuation level. The timing pattern and magnitude of this buy—concentrated accumulation by the CEO at a distressed price level—warrants careful monitoring of company fundamentals and near-term catalysts to assess whether this represents recovery positioning or value averaging into ongoing losses.